The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| 89BIO INC | COM | 282559103 | 1,800,250 | 95,000 | SH | SOLE | N/A | 95,000 | 0 | 0 | ||
| ADMA BIOLOGICS INC | COM | 000899104 | 10,059,128 | 2,726,051 | SH | SOLE | N/A | 2,726,051 | 0 | 0 | ||
| AIRSCULPT TECHNOLOGIES INC | COM | 009496100 | 646,500 | 75,000 | SH | Call | SOLE | N/A | 75,000 | 0 | 0 | |
| ALIMERA SCIENCES INC | COM NEW | 016259202 | 4,846,190 | 1,659,654 | SH | SOLE | N/A | 1,659,654 | 0 | 0 | ||
| ANNEXON INC | COM | 03589W102 | 1,618,306 | 459,746 | SH | SOLE | N/A | 459,746 | 0 | 0 | ||
| AVADEL PHARMACEUTICALS PLC | SPONSORED ADR | 05337M104 | 1,648,000 | 100,000 | SH | SOLE | N/A | 100,000 | 0 | 0 | ||
| CABALETTA BIO INC | COM | 12674W109 | 3,227,500 | 250,000 | SH | SOLE | N/A | 250,000 | 0 | 0 | ||
| CATALENT INC | COM | 148806102 | 2,168,000 | 50,000 | SH | SOLE | N/A | 50,000 | 0 | 0 | ||
| CULLINAN ONCOLOGY INC | COM | 230031106 | 538,000 | 50,000 | SH | SOLE | N/A | 50,000 | 0 | 0 | ||
| EDESA BIOTECH INC | COM | 27966L108 | 1,039,262 | 1,281,615 | SH | SOLE | N/A | 1,281,615 | 0 | 0 | ||
| ELEVATION ONCOLOGY INC | COM | 28623U101 | 755,894 | 497,299 | SH | SOLE | N/A | 497,299 | 0 | 0 | ||
| GALERA THERAPEUTICS INC | COM | 36338D108 | 3,120,000 | 1,000,000 | SH | SOLE | N/A | 1,000,000 | 0 | 0 | ||
| GERON CORP | COM | 374163103 | 2,498,985 | 778,500 | SH | SOLE | N/A | 778,500 | 0 | 0 | ||
| HERON THERAPEUTICS INC | COM | 427746102 | 5,220,000 | 4,500,000 | SH | SOLE | N/A | 4,500,000 | 0 | 0 | ||
| ICOSAVAX INC | COM | 45114M109 | 1,595,056 | 160,630 | SH | SOLE | N/A | 160,630 | 0 | 0 | ||
| IMMUNOGEN INC | COM | 45253H101 | 3,575,865 | 189,500 | SH | SOLE | N/A | 189,500 | 0 | 0 | ||
| INFLARX NV | COM | N44821101 | 892,000 | 200,000 | SH | SOLE | N/A | 200,000 | 0 | 0 | ||
| INHIBRX INC | COM | 45720L107 | 649,000 | 25,000 | SH | SOLE | N/A | 25,000 | 0 | 0 | ||
| INSPIREMD INC | COM | 45779A846 | 2,269,113 | 904,029 | SH | SOLE | N/A | 904,029 | 0 | 0 | ||
| IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 1,689,600 | 240,000 | SH | SOLE | N/A | 240,000 | 0 | 0 | ||
| JASPER THERAPEUTICS INC | COM | 471871103 | 11,487,450 | 8,385,000 | SH | SOLE | N/A | 8,385,000 | 0 | 0 | ||
| JASPER THERAPEUTICS INC | COM | 471871103 | 3,360,995 | 2,834,036 | SH | OTR | N/A | 0 | 2,834,036 | 0 | ||
| LANTHEUS HLDGS INC | COM | 516544103 | 8,392,000 | 100,000 | SH | SOLE | N/A | 100,000 | 0 | 0 | ||
| MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | 2,820,300 | 55,300 | SH | SOLE | N/A | 55,300 | 0 | 0 | ||
| OPTINOSE INC | COM | 68404V100 | 4,424,139 | 3,596,861 | SH | SOLE | N/A | 3,596,861 | 0 | 0 | ||
| POINT BIOPHARMA GLOBAL INC | COM | 730541109 | 3,107,000 | 342,936 | SH | SOLE | N/A | 342,936 | 0 | 0 | ||
| PRAXIS PRECISION MEDICINES I | COM | 74006W108 | 5,962,750 | 5,185,000 | SH | SOLE | N/A | 5,185,000 | 0 | 0 | ||
| QUIPT HOME MEDICAL CORP | COM | 74880P104 | 534,000 | 100,000 | SH | Call | SOLE | N/A | 100,000 | 0 | 0 | |
| QUIPT HOME MEDICAL CORP | COM | 74880P104 | 5,179,800 | 970,000 | SH | SOLE | N/A | 970,000 | 0 | 0 | ||
| REZOLUTE INC | COM NEW | 76200L309 | 792,000 | 400,000 | SH | SOLE | N/A | 400,000 | 0 | 0 | ||
| TELA BIO INC | COM | 872381108 | 7,557,861 | 746,087 | SH | SOLE | N/A | 746,087 | 0 | 0 | ||
| TENET HEALTHCARE CORP | COM NEW | 88033G407 | 4,223,622 | 51,900 | SH | SOLE | N/A | 51,900 | 0 | 0 | ||